Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Expo Health ; : 1-17, 2023 May 29.
Artigo em Inglês | MEDLINE | ID: mdl-37360514

RESUMO

Brain-derived neurotrophic factor (BDNF) and kisspeptin-1 (KISS-1) regulate placental development and fetal growth. The predictive value of maternal serum BDNF and KISS-1 concentrations for placental and umbilical cord levels has not yet been explored. The influence of prenatal lead (Pb) and cadmium (Cd) exposure and maternal iron status on BDNF and KISS-1 levels is also unclarified and of concern. In a pilot cross-sectional study with 65 mother-newborn pairs, we analyzed maternal and cord serum levels of pro-BDNF, mature BDNF, and KISS-1, BDNF, and KISS-1 gene expression in placenta, Pb and Cd in maternal and umbilical cord blood (erythrocytes), and placenta. We conducted a series of in vitro experiments using human primary trophoblast cells (hTCs) and BeWo cells to verify main findings of the epidemiological analysis. Strong and consistent correlations were observed between maternal serum levels of pro-BDNF, mature BDNF, and KISS-1 and corresponding levels in umbilical serum and placental tissue. Maternal red blood cell Pb levels were inversely correlated with serum and placental KISS-1 levels. Lower expression and release of KISS-1 was also observed in Pb-exposed BeWo cells. In vitro Pb exposure also reduced cellular BDNF levels. Cd-treated BeWo cells showed increased pro-BDNF levels. Low maternal iron status was positively associated with low BDNF levels. Iron-deficient hTCs and BeWo cells showed a consistent decrease in the release of mature BDNF. The correlations between maternal BDNF and KISS-1 levels, placental gene expression, and umbilical cord serum levels, respectively, indicate the strong potential of maternal serum as predictive matrix for BDNF and KISS-1 levels in placentas and fetal sera. Pb exposure and iron status modulate BDNF and KISS-1 levels, but a clear direction of modulations was not evident. The associations need to be confirmed in a larger sample and validated in terms of placental and neurodevelopmental function. Supplementary Information: The online version contains supplementary material available at 10.1007/s12403-023-00565-w.

2.
Integr Cancer Ther ; 19: 1534735420924757, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32462950

RESUMO

Background: Integrative oncology has proven to be a useful approach to control cancer symptoms and improve the quality of life (QoL) and overall health of patients, delivering integrated patient care at both physical and emotional levels. The objective of this randomized trial was to evaluate the effects of a triple intervention program on the QoL and lifestyle of women with breast cancer. Methods: Seventy-five survivors of stage IIA-IIB breast cancer were randomized into 2 groups. The intervention group (IG) received a 6-month dietary, exercise, and mindfulness program that was not offered to the control group (CG). Data were gathered at baseline and at 6 months postintervention on QoL and adherence to Mediterranean diet using clinical markers and validated questionnaires. Between-group differences at baseline and 3 months postintervention were analyzed using Student's t test for related samples and the Wilcoxon and Mann-Whitney U tests. Results: At 6 months postintervention, the IG showed significant improvements versus CG in physical functioning (p = .027), role functioning (p = .028), and Mediterranean diet adherence (p = .02) and a significant reduction in body mass index (p = .04) and weight (p = .05), with a mean weight loss of 0.7 kg versus a gain of 0.55 kg by the CG (p = .05). Dyspnea symptoms were also increased in the CG versus IG (p = .066). Conclusions: These results demonstrate that an integrative dietary, physical activity, and mindfulness program enhances the QoL and healthy lifestyle of stage IIA-IIB breast cancer survivors. Cancer symptoms may be better managed by the implementation of multimodal rather than isolated interventions.


Assuntos
Neoplasias da Mama , Sobreviventes de Câncer , Dieta Mediterrânea , Atenção Plena , Exercício Físico , Feminino , Humanos , Qualidade de Vida , Sobreviventes
3.
Environ Health Perspect ; 127(11): 117004, 2019 11.
Artigo em Inglês | MEDLINE | ID: mdl-31774309

RESUMO

BACKGROUND: Newborns in neonatal intensive care units (NICUs) are in contact with a variety of medical products whose production might include synthetic chemicals with hormonal activity. OBJECTIVES: Our aim was to assess the content of bisphenol A (BPA) and parabens (PBs) and the hormone-like activities of a subset of medical products commonly used in NICUs in prolonged intimate contact with NICU newborns. METHODS: Fifty-two NICU items were analyzed, determining the concentrations of BPA and PBs [methyl- (MeP), ethyl- (EtP), propyl- (PrP), and butylparaben (BuP)] and using the E-Screen and PALM-luciferase assays to measure the in vitro (anti-)estrogenic and (anti-)androgenic activity, respectively, of the extracts. Items found to have elevated BPA/PB content or hormone-like activities were further extracted using leaching methodologies. RESULTS: BPA was found in three-fifths and PBs in four-fifths of tested NICU items, and ∼25% and ∼10% of extracts evidenced estrogenic and anti-androgenic activity, respectively. The highest BPA content was found in the three-way stopcock (>7.000 ng/g), followed by patterned transparent film dressing, gastro-duodenal feeding tubes, sterile gloves, single-lumen umbilical catheters, and intravenous (IV) infusion extension sets (concentrations ranged from 100 to 700 ng/g BPA). A total PB concentration (∑PBs) >100 ng/g was observed in several items, including light therapy protection glasses, patterned transparent film dressing, winged IV catheters, IV infusion extension sets, and textile tape. The highest estrogenic activity [>450 pM estradiol equivalent (E2eq)] was found in small dummy nipples, three-way stopcocks, and patterned transparent film dressing and the highest anti-androgenic activity [>5 mM procymidone equivalent units per gram (Proceq/g)] in small dummy nipples and three-way stopcocks. DISCUSSION: According to these findings, neonates might be exposed to multiple sources of BPA and PBs in NICUs via inhalation, dermal, oral, and IV/parenteral routes. There is a need to address the future health implications for these extremely vulnerable patients and to adopt precautionary preventive measures as a matter of urgency. https://doi.org/10.1289/EHP5564.


Assuntos
Compostos Benzidrílicos/análise , Exposição Ambiental/análise , Unidades de Terapia Intensiva Neonatal , Parabenos/análise , Fenóis/análise , Suplementos Nutricionais/análise , Equipamentos e Provisões , Humanos , Recém-Nascido , Pomadas/análise , Têxteis/análise
4.
Int J Hyg Environ Health ; 220(4): 647-658, 2017 06.
Artigo em Inglês | MEDLINE | ID: mdl-28291591

RESUMO

BACKGROUND: In 2003 the INMA-INfancia y Medio Ambiente (Environment and Childhood) project, a Spanish national network of birth cohorts including more than 3500 participants, was set up with the aim to assess the health impacts of pre- and postnatal environmental exposures on children. The project has published more than 60 papers on maternal and environmental factors related to neuropsychological development in children, one of the main research interests within the project. With the present review, we evaluate the evidence provided by the INMA project on this topic and discuss how the data can contribute to cover the challenges that children's environmental health research will face in the coming years. RESULTS: The INMA project has contributed to provide increasing evidence of the association between prenatal exposure to persistent organic pollutants (POPs) and child neuropsychological development, but it has also shown, using innovative methodologies, that postnatal exposure to these compounds does not play a role in this association. The project has also contributed to show the detrimental influence of certain air pollutants on child neuropsychological development, as well as how a balanced maternal fish intake can protect from the potential adverse effects of prenatal exposure to mercury. Also, the project has contributed to the understanding of impacts of nutritional factors including supplement intake and vitamin D levels during pregnancy and the role of breastfeeding on the neuropsychological benefits. CONCLUSIONS: INMA findings underscore the importance of continued research on the delineation of the sensitive windows of exposure both during pregnancy and postnatally and on the combined effects of environmental exposures, denoted the exposome. In terms of health policy, INMA findings have important implications for the development of public health policies to advance the health and development of children.


Assuntos
Desenvolvimento Infantil/efeitos dos fármacos , Poluentes Ambientais/toxicidade , Animais , Encéfalo/efeitos dos fármacos , Criança , Exposição Ambiental , Humanos , Testes Neuropsicológicos , Neuropsicologia , Pesquisa
5.
Artigo em Inglês | MEDLINE | ID: mdl-26161806

RESUMO

Medicinal plants are widely used for the treatment of diseases and for the development of new drugs. This study was designed to determine the presence of hormone-like activities dependent on the activation of human estrogen receptor alpha (hERa) and/or androgen receptor (hAR) in methanol extracts prepared from three medicinal plants historically and currently used for therapeutic purposes: Ginkgo biloba leaves (GBL), Elettaria cardamomum seeds (ECS) and Plantago ovata seeds (POS). After a solid-liquid extraction (SLE) step, their effects on hERa function were assessed in MCF-7 breast cancer cells using the E-Screen bioassay, and their ability to induce hAR-mediated reporter gene expression was evaluated using the androgen-sensitive stable prostatic PALM cell line. Unlike POS extracts, GBL and ECS extracts showed estrogenic (0.07 and 0.20 nM E2Eq mg(-1), respectively) and anti-estrogenic (0.01 and 0.02 µM ICI182780Eq mg(-1), respectively) activities. ECS extracts evidenced androgenic activity (0.30 nM R1881Eq mg(-1)) and POS extracts anti-androgenic activity (22.30 µM ProcEq mg(-1)). According to these findings, these plant extracts may interfere with the endocrine system via one or more hormonal receptors, and further investigation is warranted into their role as endocrine disrupters in humans.


Assuntos
Bioensaio/métodos , Elettaria/química , Receptor alfa de Estrogênio/metabolismo , Ginkgo biloba/química , Extratos Vegetais/química , Extratos Vegetais/farmacologia , Plantago/química , Receptores Androgênicos/metabolismo , Proliferação de Células/efeitos dos fármacos , Sobrevivência Celular/efeitos dos fármacos , Relação Dose-Resposta a Droga , Humanos , Células MCF-7 , Folhas de Planta/química , Sementes/química , Relação Estrutura-Atividade
6.
BMC Complement Altern Med ; 13: 201, 2013 Jul 31.
Artigo em Inglês | MEDLINE | ID: mdl-23902919

RESUMO

BACKGROUND: Brown propolis is the major type of propolis found in Cuba; its principal component is nemorosone, the major constituent of Clusia rosea floral resins. Nemorosone has received increasing attention due to its strong in vitro anti-cancer action. The citotoxicity of nemorosone in several human cancer cell lines has been reported and correlated to the direct action it has on the estrogen receptor (ER). Breast cancer can be treated with agents that target estrogen-mediated signaling, such as antiestrogens. Phytoestrogen can mimic or modulate the actions of endogenous estrogens and the treatment of breast cancer with phytoestrogens may be a valid strategy, since they have shown anti-cancer activity. METHODS: The aim of the present investigation was to assess the capacity of nemorosone to interact with ERs, by Recombinant Yeast Assay (RYA) and E-screen assays, and to determine by comet assay, if the compound causes DNA-damaging in tumoral and non-tumoral breast cells. RESULTS: Nemorosone did not present estrogenic activity, however, it inhibited the 17-ß-estradiol (E2) action when either of both methods was used, showing their antiestrogenicity. The DNA damage induced by the benzophenone in cancer and normal breast cells presented negative results. CONCLUSION: These findings suggest that nemorosone may have therapeutic application in the treatment of breast cancer.


Assuntos
Benzofenonas/farmacologia , Antagonistas de Estrogênios/farmacologia , Estrogênios/farmacologia , Mutagênicos/farmacologia , Extratos Vegetais/farmacologia , Própole/química , Benzofenonas/química , Linhagem Celular Tumoral , Proliferação de Células/efeitos dos fármacos , Ensaio Cometa , Cuba , Dano ao DNA/efeitos dos fármacos , Avaliação Pré-Clínica de Medicamentos , Antagonistas de Estrogênios/química , Estrogênios/química , Humanos , Espectrometria de Massas , Mutagênicos/química , Extratos Vegetais/química
7.
Gac. sanit. (Barc., Ed. impr.) ; 22(6): 520-526, nov.-dic. 2008. mapas, tab, graf
Artigo em Espanhol | IBECS | ID: ibc-61241

RESUMO

Objetivos: La cloración del agua da lugar a la formación desubproductos potencialmente dañinos para la salud, entre elloslos trihalometanos, que se han hallado elevados en algunaszonas de España. En este estudio se investigan los valoresde trihalometanos en el agua de consumo suministrada porvarios sistemas de abastecimiento de la provincia de Granada,en el área de actuación de la cohorte madres-hijos de laRed INMA (Infancia y Medio Ambiente).Métodos: Se analizaron 82 muestras de agua de consumoen dos campañas de muestreo en invierno y verano de 2006.Se determinó la concentración de cloroformo, bromodiclorometano,dibromoclorometano y bromoformo, siguiendo un procedimientooptimizado basado en cromatografía de gases yespectrometría de masas.Resultados: El rango de concentración de trihalometanos totalesse situó entre 0,14 y 18,75 g/l en la campaña de inviernoy entre 0,01 y 31,87 g/l en la de verano. El compuestomayoritario fue cloroformo. La concentración media de trihalometanosen agua de origen superficial y subterráneo fue de10,13 y 1,41 g/l, respectivamente.Conclusiones: Los valores de trihalometanos encontradosson muy inferiores a la concentración máxima admisible (100g/l) establecida por la Unión Europea para estos compuestos.Estos valores varían significativamente según el origendel agua, con mayores concentraciones en áreas urbana ysemiurbana, donde el agua es mayoritariamente de origen superficial.La presencia de trihalometanos en la zona es menora la descrita en otras regiones españolas(AU)


Objectives: Drinking water chlorination generates potentiallyharmful by-products, such as trihalomethanes. Trihalomethanelevels are high in some parts of Spain. The aim of the presentstudy was to investigate trihalomethane concentrationsin drinking water from distinct water supplies in the provinceof Granada, within the framework of the Childhood and Environment(INMA) study.Methods: Eighty-two tap water samples were collected in twocampaigns during the winter and summer of 2006. An optimizedprocedure based on gas chromatography and massspectrometry was used to determine concentrations of chloroform,bromodichloromethane, dibromochloromethane, andbromoform in the samples.Results: Total trihalomethane concentrations ranged from 0.14to 18.75 g/l in winter samples and from 0.01 to 31.87 g/lin summer samples. The most abundant compound waschloroform. Mean trihalomethane concentrations were 10.13in surface waters and 1.41 g/l in ground waters.Conclusions: The trihalomethane levels found were considerablybelow the maximum permitted level of 100 g/l in the European Union. The values obtained varied widely accordingto the type of water source: the highest concentrations werefound in urban and sub-urban areas, where the water is largelyof surface origin. The presence of trihalomethanes waslower than that reported in other Spanish regions(AU)


Assuntos
Trialometanos/uso terapêutico , Consumo de Água (Saúde Ambiental) , Uso Eficiente da Água/políticas , Cloro/uso terapêutico , Medicina Preventiva/métodos , Cromatografia Gasosa/métodos , Espectrometria de Massas/métodos , Desinfecção da Água/métodos , Desinfecção da Água/prevenção & controle , Desinfecção da Água/políticas , Desinfecção/métodos , Exposição Ambiental/prevenção & controle , Desinfecção , Conservação dos Recursos Hídricos , Uso Eficiente da Água/métodos , Espanha/epidemiologia , Saúde Pública/métodos , Clorofórmio/uso terapêutico , Exposição Ambiental/economia , Exposição Ambiental/normas
8.
Environ Health Perspect ; 110(8): 743-8, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12153753

RESUMO

Endocrine disruptors can affect the endocrine system without directly interacting with receptors, for example, by interfering with the synthesis or metabolism of steroid hormones. The aromatase that converts testosterone to 17beta-estradiol is a possible target. In this paper we describe an assay that simultaneously detects aromatase inhibition and estrogenicity. The principle is similar to that of other MCF-7 estrogenicity assays, but with a fixed amount of testosterone added. The endogenous aromatase activity in MCF-7 cells converts some of the testosterone to 17beta-estradiol, which is assayed by quantifying differences in the expression level of the estrogen-induced pS2 mRNA. Potential aromatase inhibitors can be identified by a dose-dependent reduction in the pS2 mRNA expression level after exposure to testosterone and the test compound. Using this assay, we have investigated several compounds, including synthetic chemicals and phytoestrogens, for aromatase inhibition. The phytoestrogens, except genistein, were aromatase inhibitors at low concentrations (< 1 micro M) but estrogenic at higher concentrations (greater than or equal to 1 micro M), resulting in U-shaped dose-response curves. None of the tested synthetic chemicals were aromatase inhibitors. The low-dose aromatase inhibition distinguished phytoestrogens from other estrogenic compounds and may partly explain reports about antiestrogenic properties of phytoestrogens. Aromatase inhibition may play an important role in the protective effects of phytoestrogens against breast cancer.


Assuntos
Inibidores da Aromatase , Neoplasias da Mama/patologia , Inibidores Enzimáticos/farmacologia , Estrogênios não Esteroides/farmacologia , Extratos Vegetais/farmacologia , Bioensaio/métodos , Neoplasias da Mama/prevenção & controle , Técnicas de Cultura de Células , Relação Dose-Resposta a Droga , Feminino , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA